144 related articles for article (PubMed ID: 6666222)
21. [The anti-ischemic effect of isosorbide dinitrate alone and in combination with gallopamil and propranolol].
Sthler-Klich HM; Hopf R; Kaltenbach M
Z Kardiol; 1989; 78 Suppl 2():179-82; discussion 188-9. PubMed ID: 2686258
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
Saito M; Nobuyoshi M; Nakamura N; Nishiyama S; Haze K; Hiramori K; Ikeda M
Arzneimittelforschung; 1983; 33(9):1301-5. PubMed ID: 6685512
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of slow-release gallopamil in patients with stable exercise-inducible angina pectoris.
Kottkamp H; Gülker H; Emmerich K; Koch HP; Minge C
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S88-94. PubMed ID: 1284163
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation using serial exercise tests of verapamil alone and combined with isosorbide dinitrate in exertional angina].
Vázquez de Prada JA; Ruano J; Zueco J; Colman T; González-Vílchez F; Pajarón A
Rev Esp Cardiol; 1989 Oct; 42(8):513-8. PubMed ID: 2602607
[TBL] [Abstract][Full Text] [Related]
27. Anti-ischemic effects of an 80-mg tablet of isosorbide dinitrate in sustained-release form before and after 2 weeks treatment with 80 mg once daily or twice daily.
Silber S; Krause KH; Garner C; Theisen K; Jahrmärker H
Z Kardiol; 1983; 72 Suppl 3():211-7. PubMed ID: 6666224
[TBL] [Abstract][Full Text] [Related]
28. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
[TBL] [Abstract][Full Text] [Related]
29. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.
Parker JO; Farrell B; Lahey KA; Moe G
N Engl J Med; 1987 Jun; 316(23):1440-4. PubMed ID: 3574424
[TBL] [Abstract][Full Text] [Related]
30. Tolerance development during isosorbide dinitrate treatment: can it be circumvented?
Rudolph W; Blasini R; Reiniger G; Brügmann U
Z Kardiol; 1983; 72 Suppl 3():195-8. PubMed ID: 6421009
[TBL] [Abstract][Full Text] [Related]
31. [Isosorbide dinitrate in coronary heart disease. Effects of a delayed-action preparation during acute load and in chronic use].
Westermann KW; Eggert R; Kugler G; Priester G
Med Klin; 1975 Aug; 70(35):1375-9. PubMed ID: 1177792
[TBL] [Abstract][Full Text] [Related]
32. [Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
Loskot F; Novotny P; Sucic P; Schneider G
Z Kardiol; 1989; 78 Suppl 5():89-93. PubMed ID: 2698569
[TBL] [Abstract][Full Text] [Related]
33. [Long term therapy of coronary heart disease with 120 mg slow release isosorbide dinitrate once a day. Study of duration of action and development of tolerance].
Ohlmeier H; Mertens HM; Möller M; Mannebach H; Gleichmann U
Z Kardiol; 1986; 75 Suppl 3():50-6. PubMed ID: 3541419
[TBL] [Abstract][Full Text] [Related]
34. [Fendiline and isosorbide dinitrate in coronary heart disease (author's transl)].
Schäfer N; Belz GG; Stauch M; Schneider B
Dtsch Med Wochenschr; 1980 Sep; 105(36):1253-8. PubMed ID: 7428646
[TBL] [Abstract][Full Text] [Related]
35. [The efficacy of slow-release diltiazem in the treatment of stable angina of effort: a comparison between diltiazem and placebo].
Vizza CD; Sciomer S; Guagnozzi G; Cifarelli MT; Pastore LR; Dagianti A; Fedele F; Dagianti A
Cardiologia; 1993 May; 38(5):311-5. PubMed ID: 8402740
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
37. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate (ISDN) during acute and short-term administration in stable angina pectoris.
Wagner F; Gohlke-Bärwolf C; Trenk D; Jähnchen E; Roskamm H
Eur Heart J; 1991 Sep; 12(9):994-9. PubMed ID: 1936012
[TBL] [Abstract][Full Text] [Related]
38. [Avoidance of tolerance development to long term therapy with nitrates through correct dosage].
Blasini R; Reiniger G; Rudolph W
Z Kardiol; 1986; 75 Suppl 3():42-9. PubMed ID: 3541418
[TBL] [Abstract][Full Text] [Related]
39. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
Silber S; Vogler A; Theisen K
Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
[TBL] [Abstract][Full Text] [Related]
40. [High-dose single administration of isosorbide dinitrate: effect on diurnal distribution of transitory myocardial ischemia in patients with stable angina pectoris].
Hausmann D; Nikutta P; Daniel WG; Hartwig CA; Wenzlaff P; Lichtlen PR
Z Kardiol; 1989 Jul; 78(7):415-20. PubMed ID: 2672651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
